FDA released a draft of Strategic Priorities for Fiscal Year 2014-2018 for public comment at the beginning of July. Five cross-cutting strategies and four mission goals are identified. The five strategic priorities are: ● regulatory science ● globalization ● safety and quality ● smart regulation, and ● stewardship. The core mission goals are to: ● enhance oversight of FDA-regulated products ● improve and safeguard access to FDA-regulated products to benefit health ● promote better informed decisions about the use of FDA-regulated products, and ● strengthen organizational excellence and accountability.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
